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ding of these scores is useful to interpret the trauma literature 
accurately and comprehend methods of predicting patient 
outcome, including death and complications. Research into 
identifi ng more accurate injury scoring systems is ongoing 
and continues to improve.
Резюме
Существуют три вида бaлльных шкал для опреде-
ления степени тяжести повреждения. Знание и пони-
мание этих шкал облегчает понимание данных литера-
туры в области травм, представляя сжатые и аккурат-
ные методы позволяющие прогнозировать результаты 
лечения, смертности или осложнении при травмах. Ис-
следования в области идентификации более точных и 
аккуратных бальных шкал продолжаются несмотря на 
наличие в настоящего времени многочисленных шкал 
и их ростом с каждым годом увеличиваются. 
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Digoxin is commonly used in the treatment of 
chronic atrial fi brillation (AF) and heart failure. More 
than 10 percent of patients receiving the drug have 
been found to have evidence of digoxin toxicity 
when admitted to hospital. Digoxin has a narrow 
therapeutic index (therapeutic concentration 1-2 
ng/mL or 1.3-2.6 nmol/l.) with toxicity occurring 
with serum concentrations >2.5 ng/ml,. Serum 
concentration measurements must betaken at least 
6 hours after the last dose. Toxicity can occur as a 
result of deliberate or accidental self-poison or more 
commonly from drug accumulation over a period 
of time, particularly in the elderly and patients 
with associated renal impairment. Drugs  such as 
verapamil, captopril, quinine, quinidine, propafenone, 
fl ecainide, amiodarone, prazosin, spironolactone, 
tetracycline, erythromycin andcarbenoxalonecan 
also increase serum concentrations and predispose to 
toxicity. Agents causing hypokalemia or intracellular 
potassium defi ciency, hypomagnesaemia, hyper-
calcaemia and hypothyroidism can increase 
myocardial sensitivity to digoxin, despite satisfactory 
therapeutic concentrations [2].
Clinical presentation
Clinical features of toxicity include constitutional 
effects such as lethargy and weakness; gastrointestinal 
effects including anorexia, nausea and vomiting; 
neurological effects including confusion, weakness, 
paraesthesiae and, rarely, tits and acute psychosis; 
ocular disturbances including blurred vision, 
xanthopsia (yellow vision). Severe poisoning can 
cause hyperkalemia (by inhibiting the myocardial 
membrane adenosine triphosphate (ATP) pump) and 
metabolic acidosis.
Digoxin toxicity can cause any arrhythmia, and 
various conduction disturbances. The commonest 
arrhythmia and, usually, an early sign of toxicity is the 
occurrence of ventricular ectopics, which frequently 
proceed to bigeminy, trigeminy or salvos.
Arrhythmias arise from several actions of the 
drug, which include:
• enhanced automaticity, which can give rise to 
various atrial and ventricular tachyarrhythmias;
• excess vagal stimulation, predisposing to sinus 
bradycardia and atrioventricular (AV) block;
• a direct depressive effect on nodal tissue, further 
contributing to bradyarrhythmias.
When these actions are present simultaneously, 
intoxication is highly likely and can cause the 
characteristic arrhythmia of atrial tachycardia 
with block. Other arrhythmias include junctional 
bradycardia, second or third degree AV block, 
ventricular tachycardia (VT) and ventricular 
fi brillation (VF). When concomitant medication 
elevates digoxin levels, the features of toxicity may 
depend on the agent added. For instance, quioidine 
predisposes to tachyarrhythmias, whereas verapamil 
and amiodarone predispose to bradycardia and AV 
block [5].
Management
If digoxin toxicity is suspected then the following 
steps should be taken:
• stop digoxin
• correct hypokalemia if present
• check digoxin level
• monitor cardiac rhythm and correct any 
sustained haemodynamically signifi cant arrhythmia 
that occurs.
For acute overdoses, oral activated charcoal 
should be given to absorb any cardiac glycoside 
remaining in the gut and to interrupt the enterohepatic 
circulation.
Ventricular ectopics, fi rst degree AV block and 
AF with a slow rate but haemodynamic stability 
require no special therapy except drug withdrawal.
For hacmodynamically unstable bradyar-
rhythmiasand AV block IV atropine 0.3-1 mg every 
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3-5 minutes to a total of 0.04 mg/kg body weight 
should be given. It there is no response, then 
temporary transvenous pacing should be instituted. 
Beta-adrenergic agonists, such as isoprenaline, should 
be avoided because of the risk of precipitating more 
severe arrhythmias.
Supraventricular tachycardias can be treated with 
beta-blockers to control ventricular rate, but there 
is an increased risk of exacerbating AV conduction 
disturbances. Therefore, an ultra-short-acting beta-
blocker, such as IV esmolol, should be used initially 
(see Appendix A). Ventricular tachyarrhythmias can 
be treated with lidocaine and magnesium. Magnesium 
possesses signifi cant antiarrhythmic properties in 
the setting of digoxin toxicity. Phenytoin can be a 
useful treatment for ventricular or supraventricular 
tachycardias initiated by digoxin, and should be given 
as 50-100 mg IV as a slow bolus, every 5 minutes, to 
a dose not exceeding 600 mg.
For life-threatening arrhythmias, digoxin-
specifi c antibodies (Digibind) are the treatment of 
choice. Digibind can be strikingly effective for life-
threatening digoxin intoxication, especially when 
there are severe ventricular arrhythmias or 
hyperkalemia. The reversal of toxicity is rapid with 
few adverse effects, apart from the development of 
hypokalemia as the ATP pump activity is regained, 
and potassium is transferred from the extracellular 
to intracellular space. The use of Digibind should 
also be considered when more than 10 mg of digoxin 
has been ingested by previously healthy adults (4 
mg in children), or when the steady-state serum 
concentration is greater than 10 ng/mL, or the serum 
potassium level is >5 mmol/I. in the setting of severe 
intoxication, Digoxin levels may remain high, but most 
digoxin is bound to Fab fragments and is functionally 
inert. Therefore, measurement of digoxin levels is 
not reliable or useful following the administration of 
Digibind. Box 8.1 summarizes the calculation for the 
administration of Digibind.
The risk of provoking dangerous arrhythmias 
with electrical cardioversion is greatly increased in 
the presence of digoxin toxicity and is in proportion 
to the cardioversion energy used. Therefore, electrical 
cardioversion should only be used as a last resort for 
the treatment of life threatening tachyarrhythmias, 
always starting at a low energy level (i.e. 10 J). 
Overdrive pacing can be considered in patients with 
refractory ventricular arrhythmias.
Hemodialysis is not useful because the drug has a 
large volume of distribution and is extensively tissue 
bound. 
Digibind indications and dosing regime. 
Digibind administration is indicated for:
Life-threatening arrhythmias or conduction disturbance.
Serum potassium levels greater than 5 mmol/L in the 
presence of severe intoxication. 
Digoxin level >10ng/mL.
The dose of antibody depends on the body load of cardiac 
glycoside, which has to be counteracted. When requesting 
levels it is important to specify whether digoxin or 
digitoxin is to be measured as the assays differ.
To estimate the body load of digoxin or digitoxin from 
the amount ingested.
The body load of digoxin or digitoxin = the amount 
ingested X 0.80 (mg).
To calculate the body load of digoxin or digitoxin from 
the plasma or serum digoxin or digitoxin concentration.
The estimated body load (mg = plasma (serum) 
concentration of digoxin (ng/mL) X 0.0056 X body 
weight (kg).
The dose of antibody (Digibind) is about 60 times the 
body load (whether digoxin or digitoxin) rounded up to 
the nearest 40 mg. Sometimes up to 12 or 14 vials may 
be required.
Tricyclic antidepressants overdose 
Tricyclic antidepressants (TCADs) result in 
signifi cant mortality when taken in overdose due to 
the cardiovascular effects of hypotension, myocardial 
depression and arrhythmias. The onset of toxicity is 
rapid with the majority of deaths occurring within a 
few hours of presentation.
Clinical presentation
Early clinical features are due to the anticholinergic 
effects of the drug, and include dilated pupils, dry skin, 
dry mouth, decreased bowel sounds (ileus), urinary 
retention and tachycardia. Cardiovascular toxicity can 
rapidly ensue with the development of hypotension, 
arrhythmias and asystole. Toxicity results primarily 
from effects on the myocardial cell action potential, 
direct effects on vascular tone and indirect effects 
mediated by the autonomic nervous system.
TCADs can inhibit the fast-acting sodium 
channel and are therefore similar to class 1A 
antiarrhythmic drugs. Consequently, TCA 15s can 
impair cardiac conduction and prolong repolarization. 
They also have a negative inotropic effect due to 
inhibition of calcium entry into myocytes. The 
inhibition of sodium channels is pH dependent with 
acidosis aggravating cardiotoxicity. Conversely, an 
increase in pH is protective by improving cardiac 
conduction and reducing negative inotropic effects. 
1 mpaired conduction in the His-Purkinje system 
slows propagation of the ventricular depolarization 
wave, and prolongs the QRS interval. QRS interval 
prolongation is the most distinctive feature of serious 
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TCAD overdose, and is usually seen as a non-specifi c 
conduction delay on the electrocardiogram (ECG). A 
QRS duration >120 ms is a good predictor of cardiac 
and neurological toxicity, whereas a QRS duration 
>160 ms is predictive of ventricular arrhythmias. 
Prolongation of repolarization causes an increase in 
QT interval, predisposing to Torsade do Pointes. Non-
uniform slowing may cause unidirectional block and 
re-entry circuits to develop, analogous to ischaemic 
myocardium, resulting in VT; VT maybe diffi cult to 
distinguish from sinus tachycardia in the presence of 
prolonged QRS and PR intervals (P waves may be 
obscured by the preceding T wave). A 12-lead ECG 
may help reveal P waves not visible on a rhythm 
strip. VF is usually a terminal rhythm that occurs as a 
complication of VT or hypotension. The PR interval 
in TCAD overdose is often prolonged, but second or 
third degree AV block is rare. Sinus tachycardia is the 
most common rhythm disorder seen and is present in 
more than 50 per cent of patients [7].
Management
Management is generally supportive, with 
monitoring of respiration and cardiac rhythm. Owing 
to the possibility of rapid deterioration, intravenous 
access is recommended. A 12-lead ECG should be 
obtained because it may reveal QRS prolongation that 
is not evident on the single lead of a cardiac monitor.
The anticholinergic effects may delay gastric 
emptying, and a large, single dose of activated 
charcoal administration should be considered, 
particularly if ingestion has occurred within an hour 
of presentation.
Any hypoxia and electrolyte or metabolic 
disturbances should be corrected. Even in the absence 
of acidosis, if there is cardiac involvement (QRS 
prolongation >14() ms, ventricular arrhythmias) or 
hypotension, 50 mmol sodium bicarbonate should 
be administered slowly (see Appendix A). Because 
marked alkalosis can be physiologically  detrimental, 
arterial blood pi I should not exceed 7.5-7.55. 
Treatment for sinus tachycardia is not generally 
needed. First degree AV block requires no treatment, 
second (type II) or third degree AV block should be 
managed with temporary transvenous pacing. Any 
unstable ventricular tachyarrhythmias should be 
treated with direct current cardioversion (DCC); if 
recurrent, lidocaine should be administered. The use 
of other antiarrhythmic agents is limited, and may 
aggravate cardiotoxicity. Overdrive pacing should 
be considered in patients with refractory ventricular 
arrhythmias. Seizures should be treated with diazepam, 
as other anticonvulsant agents such as phenytoin may 
aggravate hypotension and arrhythmias. If seizures 
cannot be adequately controlled, paralysis and 
ventilation are indicated to prevent further acidosis. 
A fl uid challenge often corrects mild hypotension 
and may facilitate the management of more severe 
hypotension, which can be treated with inotropic and 
vasopressor agents. Noradrenaline is the vasopressor 
of choice, although dobutamine may be effective in 
the presence of a low cardiac output but adequate 
fi lling pressures.
Substance abuse 
It is estimated that almost one in four people in 
developed countries have misused recreational drugs 
at some time during their life. Therefore, independent 
of clinical practice, most doctors will have to manage 
patients with the ill effects associated with recreational 
drug abuse at some point during their career. In 
addition to their effects on the central nervous system, 
many of these agents induce profound changes in the 
heart and circulation, which are responsible for a 
signifi cant proportion of drug-related morbidity. The 
purpose of this section is to review the cardiovascular 
complications associated with some of the commonly 
misused recreational drugs [9].
Cocaine, crack, amphetamine and ecstasy 
Pharmacology
These drugs all share similar adverse effects on 
the cardiovascular system, related predominantly 
to sympathetic nervous system activation. Cocaine 
and its freebase form, “crack”, act by inhibiting the 
noradrenaline re-uptake transporter in peripheral 
nerve terminals as well as stimulating central 
nervous system outfl ow. Circulating catecholamine 
concentrations can be elevated as much as fi ve-fold in 
cocaine users. Cocaine has a short serum half-life of 
approximately 30-80 minutes, with 90 per cent being 
metabolized and excreted in the urine over a 2-week 
period. At high doses, cocaine can impair myocardial 
electrical conduction and contractility by blocking 
fast sodium and potassium channels and inhibiting 
calcium entry into myocytes. Amphetamine and 
its derivative ecstasy produce indirect sympathetic 
activation by releasing noradrenaline, dopamine and 
serotonin from central and autonomic nervous system 
terminals. The plasma half-lite varies from as little as 5 
hours to 20-30 hours depending on urine fl ow and pH 
(elimination is increased in acidic urine). Compared 
to cocaine, amphetamine lacks the local anaesthetic 
effect of inhibiting fast  sodium channels [8].
Clinical effects
Sympathetic activation can lead to varying degrees 
of tachycardia, vasoconstriction, unpredictable blood 
pressure effects and arrhythmias, depending on the 
dose taken and the presence or absence of coexisting 
cardiovascular disease. Although hypertension is 
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common, hypotension as a result of paradoxical 
central sympathetic suppression, a late relative 
catecholamine-depleted state or acute myocardial 
depression can occur. Myocardial depression may be 
caused by ischaemia, a direct toxic effect of the drug 
or mechanical complications (acute aortic rupture, 
tension pneumothorax, pneumopericardium etc.).
Chest discomfort is a common symptom 
associated with cocaine, affecting 40 per cent of 
emergency department attenders following use of 
cocaine. Myocardial infarction occurs in up to 6 per 
cent of such patients in the United States, although 
a signifi cant proportion may not offer a history of 
chest pain at all. Cocaine-related infarction usually 
occurs early (within 3 hours) after cocaine use, 
but events may occur several hours later owing to 
persistence of metabolites in the circulation. Both 
cocaine and amphetamine can cause myocardial 
ischaemia and infarction in patients with or without 
coronary artery disease. The underlying mechanisms 
are unclear, but may be related to the elevated 
catecholamine concentrations, which result in an 
increase in myocardial oxygen demand, coronary 
artery spasm, platelet aggregation and thrombus 
lormation. Cocaine can produce a procoagulant 
effect by decreasing concentrations of protein C 
and antithrombin III, and potentiating thromboxane 
production. Chronic use of cocaine and amphetamine 
can cause repetitive episodes of coronary spasm 
and paroxysms of hypertension, which may result 
in endothelial damage, coronary artery dissection 
and acceleration of atherosclerosis. Creatine kinase 
concentrations can be elevated in both cocaine and 
amphetamine abusers, and are therefore not reliable 
indicators of myocardial injury. This elevation of 
creatine kinase is probably due to rhabdomyolysis. 
Consequently, serum troponin concentrations, which 
are more sensitive and specifi c for the detection of 
myocardial necrosis, should be measured in patients 
in whom cocaine- or amphetamine-related myocardial 
infarction (MI) is suspected.
Paroxysmal increases in blood pressure can lead 
to aortic dissection or valvular damage that increases 
the risk of endocarditis affecting mainly left-sided 
heart valves. Endocarditis is often associated with 
unusual organisms such as Candida, Pseudomonas or 
Klebsiella, and frequently has an aggressive clinical 
course with marked valvular destruction, abscess 
formation and a need for surgical intervention. 
Prolonged administration of cocaine or amphetamines 
can also lead to a dilated cardiomyopathy. 
Aetiological mechanisms include repeated episodes 
of subendocardial ischaemia and fi brosis, and 
myocyte necrosis produced by exposure to excessive 
catecholamine concentrations, infectious agents and 
heavy metal contaminants (manganese is present 
in some cocaine preparations). Non-cardiogenic 
pulmonary oedema and pulmonary hypertension can 
also occur with cocaine and amphetamine abuse. 
Although the precise underlying mechanism remains 
unknown, a direct toxic effect or alterations in central 
autonomic nervous system pulmonary vasculature 
regulation has been suggested [3].
The adverse cardiovascular changes and 
sympathetic stimulation associated with cocaine and 
amphetamine ingestion predispose to myocardial 
electrical instability, precipitating a wide and 
unpredictable range of supraventricular and ventricular 
tachyarrhythmias. The presence of fi brotic scars, 
myocardial ischaemia and left ventricular hypertrophy 
can act as a substrate for re-entrant arrhythmias. The 
class 1 antiarrhythmic effect of cocaine can impair 
cardiac conduction causing prolongation of the PR, 
QRS complex and QT intervals, and a wide range of 
bradyarrhythmias including sinus arrest and higher 
degrees of AV block.
Some cocaine users practise drug inhalation in 
association with a forced Valsalva manoeuvre (the 
positive ventilatory pressure increases drug absorption 
and therefore can enhance the drug’s effect), which 
can, rarely, be complicated by a pneumothorax or 
pneumopericardium. Sudden cardiovascular collapse 
may occur as a result of myocardial ischaemia 
and infarction, arrhythmias, acute heart failure or 
mechanical complications.
Management
Similar principles apply to the management of 
the cardiovascular complications associated with 
these drugs. If the patient is agitated and anxious, 
then a benzodiazepine in sedative dosages should be 
administered as this can attenuate some of the cardiac 
and central nervous system toxicity.
In the treatment of hypertension, beta-blockers 
should be avoided, as they may be associated with 
unopposed alpha-mediated vasoconstriction leading 
to paradoxical increase in blood pressure and coronary 
artery vasoconstriction. The combined alpha- and beta-
blocker drug, labetalol, is theoretically preferable to 
selective beta-blockers. However, the alpha-blocking 
effect is relatively weak and therefore labelalol can 
also exacerbate hypertension. Hypertension can be 
safely managed with either an alpha-blocker such as 
phentolamine or with vasodilators such as hydralazine, 
nitrates and nitroprusside. When hypertensive crises 
lead to the mechanical complication of aortic dissection 
or acute valve rupture, emergency cardiothoracic 
surgery may be required.
Myocardial ischaemia should be treated initially 
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with oxygen, aspirin and benzodiazepine. If there 
is continuing ischaemia, then vasodilators such as 
nitrates or phentolamine should be administered 
in an attempt to reverse residual coronary artery 
spasm. Patients with persistent ST segment elevation 
should undergo primary angioplasty. Among patients 
undergoing coronary stenting, the potential of non-
compliance with antiplatelet medication should be 
borne in mind when choosing the type of stent [1].
The majority of arrhythmias are short lived and 
terminate spontaneously as the drug is metabolized 
and cardiac function returns to normal. Consequently, 
antiarrhythmic agents should be avoided if possible. 
Supraventricular or ventricular tachyarrhythmias 
associated with haemodynamic compromise require 
urgent DCC. Sustained haemodynamically tolerated 
supraventricular arrhythmias should be treated initially 
with adenosine. In the presence of a hyperadrenergic 
state, the short-lived inhibitory effect of adenosine 
may be a disadvantage, allowing reinduction of 
the arrhythmia. If adenosine is unsuccessful or the 
arrhythmia rapidly returns, the co-administration of 
an alpha-blocker in combination with a beta-blocker 
may be effective. In ‘body packers’ suffering from 
overdose after rupture of ingested packets of cocaine, 
calcium antagonist may accelerate gastrointestinal 
drug absorption by inducing splanchnic vasodilatation. 
Furthermore, cocaine has a complex and highly variable 
effect on myocyte calcium metabolism, producing an 
unpredictable clinical response to calcium antagonist. 
For these reasons, it may be preferable to avoid 
giving calcium antagonists to patients suspected of 
cocaine abuse. Bradyarrhythmias can be treated with 
atropine; however, its effect may be attenuated in the 
presence of a hyperadrenergic state, and temporary 
cardiac pacing may be necessary. In the presence of 
sustained ventricular tachyarrhythmias, lidocaine and 
magnesium have an acceptable safety and effi cacy 
profi le (despite theoretical concerns relating to the 
shared class 1 effects of cocaine and lidocaine). There 
is currently no reliable information on the safety and 
effi cacy of other antiarrhythmic drugs.
In animal studies using cocaine, the administration 
of sodium bicarbonate has been shown to have a 
benefi cial effect on myocardial electrical stability. 
However, this may occur at the expense of inducing 
paradoxical intracellular acidosis or adverse systemic 
metabolic changes, leading to detrimental effects on 
myocardial function. Similarly, in severe cases of 
amphetamine overdose, a forced acid diuresis may 
be successful in rapidly clearing amphetamine from 
the blood and limiting toxicity, but major detrimental 
metabolic changes in the acid-base balance can be 
induced. These treatments require intensive and 
expert monitoring and should be performed only by 
clinicians with previous metabolic experience [4, 6].
Lysergic acid diethylamide and psilocybin 
Pharmacology
Lysergic acid diethylamide (l.SD) and psilocybin 
(magic mushrooms) are commonly abused 
hallucinogenic agents that are structurally related, 
and have similar physiological, pharmacological 
and clinical effects. LSD is about 100 times more 
potent than psilocybin. Street mushrooms are 
often adulterated with LSD. Both drugs are indole 
derivatives and chemically resemble serotonin. 
Their mechanisms of action are complex and include 
agonist, partial agonist and antagonist effects at 
various serotonin receptors. The clinical effects 
are related to their serotonergic, dopaminergic and 
adrenergic activities. LSD is metabolized by the liver 
and has a plasma half-life of UK) minutes.
Clinical effects
The adrenergic effects of these drugs are usually 
mild and do not produce the profound sympathetic 
storms seen with cocaine and amphetamine. Symptoms 
corresponding to general sympathetic arousal include 
dilated pupils, tachycardia, hypertension and hyper-
refl exia. Although cardiovascular complications are 
rarely serious, supraventricular tachyarrhythmias 
and MI have been reported. Changes in serotonin-
induced platelet aggregation and sympathetically 
induced arterial vasospasm have been suggested as 
mechanisms contributing to these complications.
Management
Management is usually supportive, as the majority 
of symptoms resolve within 12 hours. Agitated patients 
should be sedated with a benzodiazepine. The use 
of neuroleptic agents should be avoided as they can 
intensify toxic effects. Supraventricular arrhythmias 
can be treated with adenosine or verapamil. Apart 
from benzodiazepines, pharmacological intervention 
tor mild to moderate hypertension is usually not 
required. Treatment for dangerously high blood 
pressure and myocardial ischaemia should follow the 




Morphine and its semi-synthetic analogue heroin 
are the most commonly misused narcotic analgesics. 
When used alone or in combination with other drugs, 
they account for over 40 per cent of drug-related 
deaths.
Heroin is slowly metabolized to morphine, which 
has a plasma half-life of 2-3 hours.
Clinical effects
Narcotic agents act centrally on the vasomotor 
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centre to increase parasympathetic and reduce 
sympathetic activity. This effect, combined with 
histamine release from mast cell degranulation, can 
result in bradycardia and hypotension. Drug-induced 
bradycardia along with enhanced automaticity can 
precipitate an increase in atrial and ventricular ectopic 
activity, AF, idioventricular rhythm or potentially lethal 
ventricular tachyarrhythmias. Some narcotic drugs 
(such as the synthetic agent, dextropropoxyphene, 
a constituent of co-proxamol) have additional 
sodium channel blocking effects, causing ECG QRS 
prolongation, and further contributing to their pro-
arrhythmic potential. It is recognized that methadone, 
commonly used in treating opioid addiction, delays 
cardiomyocyte repolarization, resulting in FCG QT 
prolongation, which is associated with Torsade de 
Pointes [9].
Bacterial endocarditis, affecting mainly right-
sided cardiac strut well-known complication of 
intravenous narcotic drug abuse, sometimes associated 
with pulmonary abscesses. Heroin overdose can 
cause non-cardiogenic pulmonary oedema, the onset 
of which can be delayed for up to 24 hours after 
admission. As the oedema fl uid has the same protein 
concentration as plasma, and the pulmonary capillary 
wedge pressure is normal, a disruption in alveolar-
capillary membrane integrity has been suggested as a 
mechanistic cause.
Management
Initial management centres around ensuring an 
adequate airway, breathing and circulation. In the 
presence of respiratory depression, severe hypotension 
and bradycardia, administration of repeated boluses 
or an infusion of a narcotic receptor antagonist, 
naloxone (Narcan), will be required, as detailed in 
Appendix A. In severe hypotension, the insertion of 
a pulmonary fl ow catheter may be needed to help 
guide fl uid and inotropic administration, and avoid 
inappropriate administration of diuretics in patients 
with non-cardiogenic pulmonary oedema, which 
requires intensive ventilatory support.
There are no useful published data to guide 
selection of antiarrhythmic agents for the treatment of 
supraventricular and ventricular tachyarrhythmias. In 
the fi rst instance, patients should be investigated, and 
hypoxic, metabolic and electrolyte defi cits corrected. 
As the misused drug is rapidly metabolized, the 
majority of arrhythmias are short lived, and it is 
therefore preferable to avoid the use of antiarrhythmic 
agents where possible to minimize the risk of pro-
arrhythmic interactions. If treatment is needed for 
supraventricular arrhythmia, conventional agents 
such as adenosine, beta-blockers, verapamil and 
digoxin have been recommended. Ventricular 
arrhythmias should be managed along conventional 
lines. Persistent bradycardia may require atropine or 
temporary cardiac pacing.
Volatile substance abuse
The abuse of volatile substances is an increasing 
problem amongst young male adolescents. The 
products used are legal, cheap and easily available. 
Abusers generally employ deep breathing techniques 
with the volatile substances contained in a plastic bag 
or bottle, a crisp packet or a soaked handkerchief to 
maximize the inhaled concentration of the substance.
Clinical effects
Following inhalation, feelings of euphoria, 
excitement and invulnerability can occur rapidly 
and are short lived. Cardiac arrhythmias are 
presumed to be the main cause of death from volatile 
substance abuse. Volatile substances may induce 
supraventricular or ventricular tachyarrhythmias by 
sympathetic activation or by myocardial sensitization 
to circulating catecholamines. Some abusers directly 
spray the substances into the oral cavity, which 
can result in intense vagal stimulation and a refl ex 
bradycardia, Profound bradycardia can evolve into 
asystole or secondary ventricular tachyarrhythmias. 
Some volatile compounds can reduce sinoatrial node 
automaticity, prolong the PR interval and induce 
atrioventricular block. Myocardial ischaemia and 
infarction have been reported and are believed to 
be caused by a combination of coronary vasospasm, 
hypoxia or excessive sympathetic stimulation. 
Hypoxia can occur as a result of respiratory 
depression, aspiration, the placement of bags over 
the head and neck, intense laryngeal oedema and 
spasm, and the formation of carboxyhaemoglobin 
or methaemoglobin. Some volatile substances are 
structurally related to the agents used in general 
anaesthesia, and can therefore cause myocardial 
depression and hypotension. Chronic abuse can 
induce a poorly characterized cardiomyopathy.
Management
Patients should be managed in a calm non-
threatening environment, with sedation if necessary. 
Hypoxia and chemical disturbances should be 
corrected to optimize myocardial electrical stability. 
Haemodynamically unstable tachyarrhythmias 
require prompt electrical cardioversion. Profound 
bradyarrhythmias may be treated cautiously with 
atropine or temporary cardiac pacing. Hypotension 
can be treated with intravenous fl uids, guided by a 
pulmonary artery catheter, if necessary. Inotropic 
agents are best avoided, if possible, as they may 
induce refractory ventricular tachyarrhythmias 
in the electrically unstable myocardium. 
Calcium administration may help to reverse 
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myocardial depression. In patients with sustained 
tachyarrhythmias, beta-blockers or amiodarone may 
help to combat sympathetic activation and are the 
antiarrhythmic drugs of choice. Cardiac ischaemia 
should be managed with oxygen, vasodilators and 




Cannabis is the most widely consumed 
recreational drug. It has a plasma half-life of 20-30 
hours and can be detected in the urine for several days 
in occasional users, and up to months in heavy users. 
Clinical effects
Cannabis has a biphasic effect on the autonomic 
nervous system, depending on the dose absorbed. 
Low or moderate doses can increase sympathetic 
and reduce parasympathetic activity, producing a 
tachycardia and an increase in cardiac output. In 
contrast, higher doses inhibit sympathetic and increase 
parasympathetic activity, resulting in bradycardia and 
hypotension. Reversible ECG abnormalities affecting 
the P and T waves, and the ST segment, have been 
reported. It is not clear whether these changes occur 
as a direct result of cannabis, independent of its effect 
on the heart rate.
Supraventricular and ventricular ectopic activity 
can occur, and arrhythmias possibly relating to 
cannabis use have been reported. In patients with 
ischaemic heart disease, cannabis increases the 
frequency of anginal symptoms at low levels of 
exercise and may be a trigger for the onset of an 
acute MI. This is believed to occur as a result of 
drug-induced increase in blood pressure, heart rate 
and myocardial contractility, increasing myocardial 
oxygen demand.
Management
In the absence of major underlying structural heart 
disease, the autonomically mediated changes in heart 
rate and blood pressure are usually well tolerated and 
therefore no treatment is needed. Where necessary, 
hypotension usually responds to intravenous fl uid 
administration. For signifi cant bradycardia, atropine 
can be administered. Patients presenting with unstable 
angina or MI should be treated conventionally.
Key points 
• The abuse of recreational drugs is common and 
it is inevitable that doctors will have to manage and 
treat their associated ill effects.
• Recreational drugs are complex and can induce 
profound changes in cardiovascular function, both 
acutely and chronically.
• Recreational drugs are often taken together, 
which can result in complex synergistic interactions 
with potentially detrimental effects.
• A high index of suspicion with early intervention 
and  management is often the key to successful 
treatment.
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Rezumat
Mai mult de 10% din pacienţii care primesc tratament 
cu digoxină prezintă semne de toxicitate manifestate prin 
aritmii şi alte dereglări. Pentru tratamentul aritmiilor cau-
zate de efectul toxic al digoxinei medicamentul de elecţie 
este Digibindul. Supradozările cu antidepresante triciclice 
se soldează cu o mortalitate înaltă cauzată de efecte cardi-
ovasculare ca hipotensiunea, depresia miocardică şi arit-
miile. Spălăturile gastrice, administrarea de cărbune acti-
vat timp de o oră de la ingestie sunt măsuri de urgenţă în 
tratamentul supradozării cu antidepresante triciclice. Con-
vulsiile vor fi  tratate cu agenţi anticonvulsivanţi. Tahiarit-
miile instabile ventriculare vor fi  tratate prin cardioversie. 
Utilizarea drogurilor recreaţionale pot induce schimbări 
profunde ale sistemului cardiovascular. Utilizarea con-
comitentă a mai multor tipuri cu interacţiuni sinergiste şi 
efecte periculoase pentru viaţă creează difi cultăţi în mana-
gementul terapeutic.
Summary
More than 10% of patient receiving the drug have been 
found to have evidence of digoxin toxicity when admitted 
to hospital. Digoxin toxicity can cause any arrhythmia, 
and various conduction disturbance. For life-threatening 
arrhythmias, digoxin specifi c antibodies (Digibind) are the 
treatment of choice. Tricyclic antidepressants (TCADs) 
result in signifi cant mortality when taken in overdose duet 
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o the cardiovascular effects of hypotension, myocardial 
depression and arrhythmias. The anticholinergic effects 
may delay gastric emptying, and a large, single dose of 
activated charcoal administration should be considered, 
particularly if ingestion has occurred within an hour of 
presentation. Any hypoxia and electrolyte or metabolic 
disturbances should be corrected. Seizures should be 
treated with diazepam, as other anticonvulsant agents. 
Recreational drugs are complex and can induce profound 
changes in cardiovascular function, both acutely and 
chronically. Recreational drugs are often taken together, 
which can result in complex synergistic interactions with 
potentially detrimental effects. A high index of suspicion 
with early intervention and  management is often the key 
to successful treatment.
Резюме
Более 10% больных, принимающих лечение ди-
гоксином имеют признаки интоксикации проявляю-
щиеся различными видами нарушения ритма и прово-
димости сердца. Для лечения аритмии, возникающей 
вследствие токсического действия дигоксина, препара-
том выбора является Digibind. Прием и передозировка 
антидепрессантами сопровождается высокой леталь-
ностью, вызванной нарушениями сердечнососудистой 
системы: гипотонией, угнетением миокарда и аритмии. 
Промывание желудка, прием активированного угля в 
первые часы после приема имеют положительный эф-
фект. Лечение судорог проводится противосудорожны-
ми препаратами. При нестабильной желудочковой та-
хикардии показана кардиверсия. Прием наркотических 
средств приводят к глубокими нарушениям сердечно-
сосудистой системы. Одновременный прием двух и 
более препаратов приводит к возникновению опасных 
для жизни нарушений, что затрудняет процесс лечения 
этих больных.
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Secondary unstable angina
A number of conditions alter the myocardial 
supply/demand relationship through mechanisms 
other than arterial obstruction and may also result 
in myocardial ischemia (table 1). It is important to 
note that presence of one of these conditions does not 
preclude the possibility of concomitant obstructive 
coronary disease. Thus, any patient with symptoms of 
angina should be evaluated for obstructive coronary 
disease before the syndrome is considered secondary 
to an unrelated condition [1].
Acute coronary syndrome in patients with 
diabetes mellitus
Patients with diabetes are at increased risk 
for coronary artery disease in general, and ACS in 
particular.
In addition to higher risk of developing ACS, 
diabetics have worse outcomes compared to 
nondiabetics. Adverse events are more frequent, 
including arrhythmia, cardiogenic shock, heart failure, 
renal failure, and death. At angiography, diabetics are 
more likely to have left main or three-vessel coronary 
disease.
Primary ACS therapy in diabetics
The treatment for ACS in patients with diabetes 
is similar to that for nondiabetics. Medical therapies 
including aspirin, beta-blockers, ACE inhibitors, 
statins, and IIB/IIIA inhibitors have been shown to 
have similar or greater impact on outcomes among 
diabetics compared to nondiabetics. Primary PCI and 
thrombolysis for STEMI also have similar or greater 
effi cacy among diabetics. Older literature suggested 
that beta-blockers should be avoided in diabetics 
due to concerns of masking hypoglycemic episodes 
through blockade of the sympathetic nervous system. 
In recent years, however, many trials have shown 
defi nitive benefi t for beta-blockers following ACS 
in diabetic patients. Patients must be advised that 
beta-blockers at high closes may mask symptoms 
of hypoglycemia, which should provide further 
motivation for close blood glucose monitoring in this 
population [1,2].
Glycemic control in diabetics with ACS
There is some evidence that tighter glycemic 
control among diabetics with ACS improves 
outcomes. The DIGAMI trial randomized 620 
diabetic patients with STEMI to routine care or 
intensive therapy with intravenous insulin infusion, 
and found that intensive therapy reduced long-term 
mortality,6 However, more recent studies have not 
confi rmed this benefi t [4].
The ACC/AHA guidelines for STEMI give a 
class I recommendation to insulin use to normalize 
blood glucose in patients with a complicated course, 
regardless of whether they have diabetes. A class IIa 
recommendation was given to use of an insulin infusion 
in all other patients with Ml with hyperglycemia. table 
2 illustrates sample insulin orders for an ACS patient 
based on blood glucose levels [11].
A special area of consideration for diabetics 
with ACS is revascularization with coronary artery 
bypass surgery (CABG). For patients with STEMI, 
CABG is usually not an option for primary therapy 
given the need for rapid revas cularization, which 
